Cargando…
Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study
BACKGROUND: Uganda’s current guidelines recommend immediate initiation of Anti-Retroviral Therapy (ART) for persons living with HIV in order to reduce HIV/AIDS related morbidity and mortality. However, not all eligible PLHIV initiate ART within the recommended time following HIV diagnosis. We assess...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843953/ https://www.ncbi.nlm.nih.gov/pubmed/36647104 http://dx.doi.org/10.1186/s12913-023-09052-z |
_version_ | 1784870514343280640 |
---|---|
author | Kiyingi, Micheal Nankabirwa, Joaniter I. Sekaggya-Wiltshire, Christine Nangendo, Joan Kiweewa, John M. Katahoire, Anne R. Semitala, Fred C. |
author_facet | Kiyingi, Micheal Nankabirwa, Joaniter I. Sekaggya-Wiltshire, Christine Nangendo, Joan Kiweewa, John M. Katahoire, Anne R. Semitala, Fred C. |
author_sort | Kiyingi, Micheal |
collection | PubMed |
description | BACKGROUND: Uganda’s current guidelines recommend immediate initiation of Anti-Retroviral Therapy (ART) for persons living with HIV in order to reduce HIV/AIDS related morbidity and mortality. However, not all eligible PLHIV initiate ART within the recommended time following HIV diagnosis. We assessed the prevalence and factors associated with delayed ART initiation among PLHIV referred for ART initiation, five years since rolling out the test and treat guidelines. METHODS: In this cross-sectional study, we enrolled adult patients referred to Mulago Immune Suppressive Syndrome (Mulago ISS) clinic for ART initiation from January 2017 to May 2021. We collected data on socio-demographics, HIV diagnosis and referral circumstances, and time to ART initiation using a questionnaire. The outcome of interest was proportion of patients that delayed ART, defined as spending more than 30 days from HIV diagnosis to ART initiation. We performed multivariable logistic regression and identified significant factors. RESULTS: A total of 312 patients were enrolled of which 62.2% were female. The median (inter-quartile range [IQR]) age and baseline CD4 count of the patients were 35 (28–42) years and 315 (118.8–580.5) cells/μL respectively. Forty-eight (15.4%) patients delayed ART initiation and had a median (IQR) time to ART of 92 (49.0–273.5) days. The factors associated with delayed ART initiation were; 1) having had the HIV diagnosis made from a private health facility versus public, (adjusted odds ratio [aOR] = 2.4 (95% confidence interval [CI] 1.1–5.5); 2) initial denial of positive HIV test results, aOR = 5.4 (95% CI: 2.0–15.0); and, 3) having not received a follow up phone call from the place of HIV diagnosis, aOR = 2.8 (95% CI: 1.2–6.8). CONCLUSION: There was significant delay of ART initiation among referred PLHIV within 5 years after the rollout of test and treat guidelines in Uganda. Health system challenges in the continuity of HIV care services negatively affects timely ART initiation among referred PLHIV in Uganda. |
format | Online Article Text |
id | pubmed-9843953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98439532023-01-18 Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study Kiyingi, Micheal Nankabirwa, Joaniter I. Sekaggya-Wiltshire, Christine Nangendo, Joan Kiweewa, John M. Katahoire, Anne R. Semitala, Fred C. BMC Health Serv Res Research BACKGROUND: Uganda’s current guidelines recommend immediate initiation of Anti-Retroviral Therapy (ART) for persons living with HIV in order to reduce HIV/AIDS related morbidity and mortality. However, not all eligible PLHIV initiate ART within the recommended time following HIV diagnosis. We assessed the prevalence and factors associated with delayed ART initiation among PLHIV referred for ART initiation, five years since rolling out the test and treat guidelines. METHODS: In this cross-sectional study, we enrolled adult patients referred to Mulago Immune Suppressive Syndrome (Mulago ISS) clinic for ART initiation from January 2017 to May 2021. We collected data on socio-demographics, HIV diagnosis and referral circumstances, and time to ART initiation using a questionnaire. The outcome of interest was proportion of patients that delayed ART, defined as spending more than 30 days from HIV diagnosis to ART initiation. We performed multivariable logistic regression and identified significant factors. RESULTS: A total of 312 patients were enrolled of which 62.2% were female. The median (inter-quartile range [IQR]) age and baseline CD4 count of the patients were 35 (28–42) years and 315 (118.8–580.5) cells/μL respectively. Forty-eight (15.4%) patients delayed ART initiation and had a median (IQR) time to ART of 92 (49.0–273.5) days. The factors associated with delayed ART initiation were; 1) having had the HIV diagnosis made from a private health facility versus public, (adjusted odds ratio [aOR] = 2.4 (95% confidence interval [CI] 1.1–5.5); 2) initial denial of positive HIV test results, aOR = 5.4 (95% CI: 2.0–15.0); and, 3) having not received a follow up phone call from the place of HIV diagnosis, aOR = 2.8 (95% CI: 1.2–6.8). CONCLUSION: There was significant delay of ART initiation among referred PLHIV within 5 years after the rollout of test and treat guidelines in Uganda. Health system challenges in the continuity of HIV care services negatively affects timely ART initiation among referred PLHIV in Uganda. BioMed Central 2023-01-16 /pmc/articles/PMC9843953/ /pubmed/36647104 http://dx.doi.org/10.1186/s12913-023-09052-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kiyingi, Micheal Nankabirwa, Joaniter I. Sekaggya-Wiltshire, Christine Nangendo, Joan Kiweewa, John M. Katahoire, Anne R. Semitala, Fred C. Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study |
title | Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study |
title_full | Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study |
title_fullStr | Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study |
title_full_unstemmed | Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study |
title_short | Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study |
title_sort | predictors of delayed anti-retroviral therapy initiation among adults referred for hiv treatment in uganda: a cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843953/ https://www.ncbi.nlm.nih.gov/pubmed/36647104 http://dx.doi.org/10.1186/s12913-023-09052-z |
work_keys_str_mv | AT kiyingimicheal predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy AT nankabirwajoaniteri predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy AT sekaggyawiltshirechristine predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy AT nangendojoan predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy AT kiweewajohnm predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy AT katahoireanner predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy AT semitalafredc predictorsofdelayedantiretroviraltherapyinitiationamongadultsreferredforhivtreatmentinugandaacrosssectionalstudy |